Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead  — Boosted by Taxpayers

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths...
read more
Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

Gilead and Novo Nordisk Present New Data from Proof-of-Concept Trial in NASH

FOSTER CITY, Calif. & BAGSVÆRD,&nbs...
read more
Gilead says it has ramped up production of remdesivir by 50-fold

Gilead says it has ramped up production of remdesivir by 50-fold

Gilead ramps up production of its coronavirus drug...
read more